Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Watts

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Health Affairs Scholar|May 17, 2024
340B Contract pharmacy growth by pharmacy ownership: 2009-2022Claire McGlave, John P Bruno, Elizabeth Watts, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|October 22, 2016
Beyond borders: on the influence of the creationist movement on the educational landscape in the USA and RussiaElizabeth Watts, Uwe Hossfeld, Irina Tolstikova, et al.
International Journal of Antimicrobial Agents|April 27, 2007
The effect of amalgam exposure on mercury- and antibiotic-resistant bacteriaDerren Ready, Jonathan Pratten, Nicola Mordan, et al.
JAMA Health Forum|October 4, 2024
340B Participation and Safety Net Engagement Among Federally Qualified Health CentersElizabeth Watts, Claire McGlave, Nicole Quinones, et al.
Vaccine: X|January 23, 2023
Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030Salin Sriudomporn, Elizabeth Watts, So Yoon Sim, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|February 26, 2019
Ernst Haeckel's embryology in biology textbooks in the German Democratic Republic, 1951-1988Uwe Hossfeld, Karl Porges, Georgy S Levit, et al.
JAMA Health Forum|August 4, 2023
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022Sayeh Nikpay, Claire C McGlave, John P Bruno, et al.
Health Affairs (Project Hope)|August 4, 2020
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30So Yoon Sim, Elizabeth Watts, Dagna Constenla, et al.
Social Science & Medicine (1982)|April 24, 2022
A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) projectBryan Patenaude, Deborah Odihi, Salin Sriudomporn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life ApproachesElizabeth Watts, So Yoon Sim, Dagna Constenla, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Health Affairs Scholar|May 17, 2024
340B Contract pharmacy growth by pharmacy ownership: 2009-2022Claire McGlave, John P Bruno, Elizabeth Watts, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|October 22, 2016
Beyond borders: on the influence of the creationist movement on the educational landscape in the USA and RussiaElizabeth Watts, Uwe Hossfeld, Irina Tolstikova, et al.
International Journal of Antimicrobial Agents|April 27, 2007
The effect of amalgam exposure on mercury- and antibiotic-resistant bacteriaDerren Ready, Jonathan Pratten, Nicola Mordan, et al.
JAMA Health Forum|October 4, 2024
340B Participation and Safety Net Engagement Among Federally Qualified Health CentersElizabeth Watts, Claire McGlave, Nicole Quinones, et al.
Vaccine: X|January 23, 2023
Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030Salin Sriudomporn, Elizabeth Watts, So Yoon Sim, et al.
Theory in Biosciences = Theorie in Den Biowissenschaften|February 26, 2019
Ernst Haeckel's embryology in biology textbooks in the German Democratic Republic, 1951-1988Uwe Hossfeld, Karl Porges, Georgy S Levit, et al.
JAMA Health Forum|August 4, 2023
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022Sayeh Nikpay, Claire C McGlave, John P Bruno, et al.
Health Affairs (Project Hope)|August 4, 2020
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30So Yoon Sim, Elizabeth Watts, Dagna Constenla, et al.
Social Science & Medicine (1982)|April 24, 2022
A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) projectBryan Patenaude, Deborah Odihi, Salin Sriudomporn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life ApproachesElizabeth Watts, So Yoon Sim, Dagna Constenla, et al.
Pageof 3